Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Foghorn Therapeutics (FHTX) Amortization of Deferred Charges (2020 - 2021)

Historic Amortization of Deferred Charges for Foghorn Therapeutics (FHTX) over the last 2 years, with Q4 2021 value amounting to $58000.0.

  • Foghorn Therapeutics' Amortization of Deferred Charges fell 169.49% to $58000.0 in Q4 2021 from the same period last year, while for Sep 2022 it was $58000.0, marking a year-over-year decrease of 8181.82%. This contributed to the annual value of $318000.0 for FY2021, which is 3361.34% up from last year.
  • Latest data reveals that Foghorn Therapeutics reported Amortization of Deferred Charges of $58000.0 as of Q4 2021, which was down 169.49% from $88000.0 recorded in Q3 2021.
  • In the past 5 years, Foghorn Therapeutics' Amortization of Deferred Charges registered a high of $88000.0 during Q3 2021, and its lowest value of $53000.0 during Q3 2020.